BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14756060)

  • 1. [Effect of antilipemic therapy on patients with diabetes mellitus and obesity].
    Ungureanu D; Coman A; Maftei M; Popovici I; Artenie A; Artenie R
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):551-5. PubMed ID: 14756060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood lipids profile in obese or overweight patients.
    Szczygielska A; Widomska S; Jaraszkiewicz M; Knera P; Muc K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):343-9. PubMed ID: 15323217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antilipemic therapy in dyslipidemias in obese non-insulin-dependent diabetics (ONIDDM)].
    Palel G; Coman A; Petrovanu R; Ungureanu D; Cojocaru M
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):120-2. PubMed ID: 10756782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic effects of hypolipemic drugs on aged type 2 diabetes].
    Palel G; Coman A; Petrovanu R; Ungureanu D
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(3):518-20. PubMed ID: 12092185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients.
    Bhan V; Yan RT; Leiter LA; Fitchett DH; Langer A; Lonn E; Tan M; Silagy S; Goodman SG; Yan AT;
    Am J Cardiol; 2010 Nov; 106(9):1270-6. PubMed ID: 21029823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationships between anthropometric measurements, serum vitamin A and E concentrations and lipid profiles in overweight and obese subjects.
    Viroonudomphol D; Pongpaew P; Tungtrongchitr R; Changbumrung S; Tungtrongchitr A; Phonrat B; Vudhivai N; Schelp FP
    Asia Pac J Clin Nutr; 2003; 12(1):73-9. PubMed ID: 12737014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The usefulness of total cholesterol and high density lipoprotein--cholesterol ratio in interpreting lipid profile results of diabetes mellitus patients.
    Mshelia DS; Garbati MA; Ndahi AA; Mamza YP; Sheikh HA
    Niger J Clin Pract; 2009 Dec; 12(4):345-9. PubMed ID: 20329668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients.
    Seyoum B; Abdulkadir J; Berhanu P; Feleke Y; Mengistu Z; Worku Y; Ayana G
    Ethiop Med J; 2003 Jan; 41(1):1-8. PubMed ID: 12764995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM).
    Uddin F; Miah AK
    Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):64-72. PubMed ID: 8815864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of quality control indices in moderately hypocaloric Mediterranean diet for treatment of obesity.
    De Lorenzo A; Petroni ML; De Luca PP; Andreoli A; Morini P; Iacopino L; Innocente I; Perriello G
    Diabetes Nutr Metab; 2001 Aug; 14(4):181-8. PubMed ID: 11716286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids.
    Fagerberg B; Berglund A; Andersson OK; Berglund G
    J Hypertens; 1992 Sep; 10(9):1053-61. PubMed ID: 1328365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).
    May HT; Anderson JL; Pearson RR; Jensen JR; Horne BD; Lavasani F; Yannicelli HD; Muhlestein JB
    Am J Cardiol; 2008 Feb; 101(4):486-9. PubMed ID: 18312763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation.
    Tam LS; Tomlinson B; Chu TT; Li M; Leung YY; Kwok LW; Li TK; Yu T; Zhu YE; Wong KC; Kun EW; Li EK
    Rheumatology (Oxford); 2008 May; 47(5):718-23. PubMed ID: 18400833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481].
    Scott R; Best J; Forder P; Taskinen MR; Simes J; Barter P; Keech A;
    Cardiovasc Diabetol; 2005 Aug; 4():13. PubMed ID: 16111499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum resistin is related to plasma HDL cholesterol and inversely correlated with LDL cholesterol in diabetic and obese humans.
    Owecki M; Nikisch E; Miczke A; Pupek-Musialik D; Sowiński J
    Neuro Endocrinol Lett; 2010; 31(5):673-8. PubMed ID: 21173741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats.
    Agil A; Navarro-Alarcón M; Ruiz R; Abuhamadah S; El-Mir MY; Vázquez GF
    J Pineal Res; 2011 Mar; 50(2):207-12. PubMed ID: 21087312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.